Adept adds two support staff

For expanding range of data acquisition products

Adept Scientific, based in Letchworth, Hertfordshire, UK, has taken on two new members of staff to support its expanding range of data acquisition products (DAQ).

Henrique da Silva will concentrate on DAQ sales. He has an MSc in Electronics & Computer Engineering.

Elizabeth Northrop (Lilly) will focus on technical support. She has an MEng in Systems Engineering.

With offices in the UK, Germany and throughout the Nordic region, Adept Scientific is a supplier of software and hardware products for research, scientific, engineering and technical applications on desktop computers.

You may also like

Research & Development

Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates

The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Research & Development

LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint

Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Research & Development

Fasenra for EGPA: addressing unmet needs

Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Hi Tech Manufacturing

New chillers for laboratories

Expansion of the Minichiller range with more powerful models
Research & Development

Neurolentech partners with Kaerus Bioscience to advance neurodevelopmental disorder research

Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes
Research & Development

Kynos Therapeutics’ KMO inhibitor demonstrates safety and tolerability in Phase I study

The lead drug candidate, KNS366, demonstrated its safety and tolerability in healthy adult participants in a Phase I trial
Research & Development

SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials

Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Subscribe now